← FDA Drug Approvals (Drugs@FDA)
FOUNDAYO
NDA · New Drug Application · Sponsor: ELI LILLY AND CO · Approved 2026-04-01
Drug application
- FDA Application #
NDA220934- Application type
- New Drug Application
- Brand name
- FOUNDAYO
- Generic name
- ORFORGLIPRON
- Active ingredients
- ORFORGLIPRON CALCIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ELI LILLY AND CO
- Manufacturer
- Eli Lilly and Company
- First approval
- 2026-04-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown